STAT+: Merck’s RSV drug approval and a drug manufacturer winds down
And more biotech news brought to you by The Readout.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning, there are some important hearings happening on the Hill today:
Anne Wojcicki, founder of genetic testing firm 23andMe, will be testifying before a House committee about the company’s bankruptcy and related concerns around data privacy. Also, NIH director Jay Bhattacharya will appear before a Senate committee about Trump’s proposed cuts to the agency’s budget and research funding. STAT reporters will be closely watching both hearings — check back in for our coverage.
